FDA issued a Warning Letter to Opto-Pharm Pte Ltd. on 3/16/2017 as a result of this inspection.
483 Opto-Pharm Pte Mar 2016

483 Opto-Pharm Pte Mar 2016

Linda Murphy FDA$119.00 - Available Now

FDA investigators audited the Opto-Pharm Pte - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 22 Mar 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Mar 2016
  • Location: Singapore, Singapore
  • FEI: 3005320466
Add To Cart